Media Inquiries

If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or by phone at 240.760.6600.

News and Events

engineered natural killer cells (yellow) can expand in solid tumors and kill tumor cells (red)

Stem cell–derived natural killer cells engineered to attack solid tumors

Cancer-killing natural killer cells could pave the way to off-the-shelf immunotherapy for solid tumors.

With new database, NCATS data is poised to support development of precision cancer therapies

Data from thousands of compounds and nearly 200 cancer cell lines screened at the National Center for Advancing Translational Sciences are available through a new CellMiner database.

Andre Nussenzweig elected to the National Academy of Sciences

Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, has been elected to the National Academy of Sciences in recognition of his distinguished and continuing achievements in original research. He investigates the mechanisms that maintain genomic stability and prevent cancer, particularly in DNA repair pathways.

Young male doctor with an older male patient.

Clinical trial researches drug therapy for prostate cancer

A clinical trial led by William Douglas Figg Sr., Pharm.D., Senior Investigator in the Genitourinary Malignancies Branch is researching a drug therapy for advanced prostate cancer.

In Memoriam: W. Michael Kuehl, M.D.

The CCR community is deeply saddened by the recent passing of W. Michael Kuehl, M.D., former Senior Investigator in the Genetics Branch.

Naomi Taylor and Peter Choyke elected to the Association of American Physicians

Naomi Taylor, M.D., Ph.D., Senior Investigator in the Pediatric Oncology Branch, and Peter L. Choyke, M.D., F.A.C.R., Chief and Senior Investigator of the Molecular Imaging Branch, were elected as members of the Association of American Physicians (AAP). Each year, the AAP elects 70 new members to honor their outstanding credentials and achievements in basic or translational biomedical research.

Clinical trial researching stem cell therapy for acute myeloid leukemia

A clinical trial led by Nirali N. Shah, M.D., M.H.Sc., Lasker Clinical Research Scholar in the Pediatric Oncology Branch, is researching hematopoietic stem cell transplants and therapy for acute myeloid leukemia.

Andre Nussenzweig and Sandra Wolin elected to American Academy of Arts and Sciences

Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, and Sandra L. Wolin, M.D., Ph.D., Chief of the RNA Biology Laboratory, have been elected to the American Academy of Arts and Sciences.

Clinical trial researching chemotherapy for bile duct cancer

A clinical trial led by Jonathan M. Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching chemotherapy for liver-only cholangiocarcinoma.

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma.

How immunotherapy before surgery boosts systemic immunity in head and neck cancer

Some evidence suggests that immunotherapy before surgery to remove head and neck tumors can decrease the chances of cancer recurrence, but the reasons for this observation are unknown. New research details how the treatment regimen boosts the number and dispersion of tumor-fighting immune cells throughout the body.

Clinical trial researching therapy for blood cancers

A clinical trial led by Christopher Kanakry, M.D., Lasker Clinical Research Scholar in the Center for Immuno-Oncology, is researching blood stem cell transplants for blood cancers such as leukemias or lymphomas.

Breadcrumb

News and Events